Akebia Therapeutics Inc. buy Piper Sandler
Start price
14.03.25
/
50%
€1.97
Target price
14.03.26
€5.53
Performance (%)
-34.31%
End price
15.03.26
€1.30
Summary
This prediction ended on 15.03.26 with a price of €1.30. Massive losses of -34.31% were the result for the BUY prediction by Piper_Sandler. Piper_Sandler has a follow-up prediction for Akebia Therapeutics Inc. where he still thinks Akebia Therapeutics Inc. is a Buy. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akebia Therapeutics Inc. | 4.504% | 4.504% | -23.551% |
| iShares Core DAX® | 3,59 % | 3,93 % | 15,38 % |
| iShares Nasdaq 100 | 5,81 % | 5,52 % | 41,46 % |
| iShares Nikkei 225® | 4,08 % | 8,46 % | 48,95 % |
| iShares S&P 500 | 4,14 % | 4,04 % | 31,59 % |
Comments by Piper_Sandler for this prediction
In the thread Akebia Therapeutics Inc. diskutieren
Akebia Therapeutics, Inc. (NASDAQ: AKBA) had its price target raised by analysts at Piper Sandler from $4.00 to $6.00. They now have an "overweight" rating on the stock.
Ratings data for AKBA provided by MarketBeat
In the thread Trading Akebia Therapeutics Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Current prediction by Piper_Sandler for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€1.29
06.02.26
06.02.26
€3.39
06.02.27
06.02.27
-7.15%
16.04.26
16.04.26
Stopped prediction by Piper_Sandler for Akebia Therapeutics Inc.
Akebia Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.92
31.05.23
31.05.23
-
31.05.24
31.05.24
13.76%
01.06.24
01.06.24